↓ Skip to main content

PLOS

Chronic Cladribine Administration Increases Amyloid Beta Peptide Generation and Plaque Burden in Mice

Overview of attention for article published in PLOS ONE, October 2012
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
39 Mendeley
Title
Chronic Cladribine Administration Increases Amyloid Beta Peptide Generation and Plaque Burden in Mice
Published in
PLOS ONE, October 2012
DOI 10.1371/journal.pone.0045841
Pubmed ID
Authors

Crystal D. Hayes, Debleena Dey, Juan Pablo Palavicini, Hongjie Wang, Wataru Araki, Madepalli K. Lakshmana

Abstract

The clinical uses of 2-chloro-2'-deoxyadenosine (2-CDA) or cladribine which was initially prescribed to patients with hematological and lymphoid cancers is now extended to treat patients with multiple sclerosis (MS). Previous data has shown that 2-CDA has high affinity to the brain and readily passes through the blood brain barrier reaching CSF concentrations 25% of that found in plasma. However, whether long-term administration of 2-CDA can lead to any adverse effects in patients or animal models is not yet clearly known.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 3%
Canada 1 3%
Unknown 37 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 21%
Student > Ph. D. Student 6 15%
Professor > Associate Professor 4 10%
Student > Master 4 10%
Student > Bachelor 3 8%
Other 8 21%
Unknown 6 15%
Readers by discipline Count As %
Neuroscience 10 26%
Medicine and Dentistry 9 23%
Agricultural and Biological Sciences 3 8%
Psychology 3 8%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 3 8%
Unknown 10 26%